科布斯製藥控股公司
US ˙ NasdaqCM ˙ US21833P3010

簡介

本頁面提供了有關 Moran Sean F. 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Moran Sean F.已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:CRBP / Corbus Pharmaceuticals Holdings, Inc. Chief Financial Officer 96,694
US:NVIV / InVivo Therapeutics Holdings Corp. Acting Chief Financial Officer 60,000
如何解讀這些圖表

以下圖表顯示了在Moran Sean F.進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

CRBP / Corbus Pharmaceuticals Holdings, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 CRBP / Corbus Pharmaceuticals Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2022-08-10 CRBP Moran Sean F. 20,000 0.2599 667 7.7970 5,198 251 12.0000 2,794 53.75
2022-05-16 CRBP Moran Sean F. 12,000 0.3000 400 9.0000 3,600
2022-03-10 CRBP Moran Sean F. 15,000 0.3700 500 11.1000 5,550
2019-05-14 CRBP Moran Sean F. 100 7.1200 3 213.6000 712
2019-03-14 CRBP Moran Sean F. 1,500 6.6700 50 200.1000 10,005
2018-05-15 CRBP Moran Sean F. 4,000 5.7700 133 173.1000 23,080
2018-03-14 CRBP Moran Sean F. 3,100 6.6000 103 198.0000 20,460
2017-11-10 CRBP Moran Sean F. 1,500 7.0400 50 211.2000 10,560
2017-08-11 CRBP Moran Sean F. 2,500 5.9100 83 177.3000 14,775
2017-05-11 CRBP Moran Sean F. 3,300 6.1400 110 184.2000 20,262
2017-03-13 CRBP Moran Sean F. 2,000 9.6000 67 288.0000 19,200
2016-12-02 CRBP Moran Sean F. 1,500 7.2000 50 216.0000 10,800
2016-09-08 CRBP Moran Sean F. 30,800 5.1200 1,027 153.6000 157,696
2016-08-26 CRBP Moran Sean F. 17,900 3.9200 597 117.6000 70,168
2016-08-18 CRBP Moran Sean F. 65,000 3.4800 2,167 104.4000 226,200
2016-08-17 CRBP Moran Sean F. 83,960 3.1900 2,799 95.7000 267,832
2016-05-19 CRBP Moran Sean F. 27,250 2.3700 908 71.1000 64,582
2016-05-18 CRBP Moran Sean F. 30,000 2.3900 1,000 71.7000 71,700
2015-12-11 CRBP Moran Sean F. 1,000 1.5590 33 46.7700 1,559
2015-12-10 CRBP Moran Sean F. 1,000 1.6110 33 48.3300 1,611
2015-12-09 CRBP Moran Sean F. 1,000 1.6700 33 50.1000 1,670
2015-12-08 CRBP Moran Sean F. 1,000 1.6820 33 50.4600 1,682
2015-12-07 CRBP Moran Sean F. 1,000 1.6890 33 50.6700 1,689
2015-12-04 CRBP Moran Sean F. 1,000 1.7200 33 51.6000 1,720
2015-12-02 CRBP Moran Sean F. 1,000 1.7899 33 53.6970 1,790
2015-11-24 CRBP Moran Sean F. 1,500 1.7800 50 53.4000 2,670
2015-11-20 CRBP Moran Sean F. 1,500 1.6987 50 50.9610 2,548
2015-11-18 CRBP Moran Sean F. 1,500 1.7100 50 51.3000 2,565
2015-11-17 CRBP Moran Sean F. 1,500 1.7220 50 51.6600 2,583
2015-11-16 CRBP Moran Sean F. 2,000 1.6860 67 50.5800 3,372
2015-09-16 CRBP Moran Sean F. 5,000 2.1210 167 63.6300 10,605
2015-09-15 CRBP Moran Sean F. 5,000 2.1440 167 64.3200 10,720
2015-09-14 CRBP Moran Sean F. 5,000 1.9640 167 58.9200 9,820
2015-09-11 CRBP Moran Sean F. 5,000 1.8468 167 55.4040 9,234
2015-08-21 CRBP Moran Sean F. 1,400 2.0564 47 61.6920 2,879
2015-08-18 CRBP Moran Sean F. 1,000 1.9164 33 57.4920 1,916
2015-06-09 CRBP Moran Sean F. 6,500 3.0000 217 90.0000 19,500
2014-12-18 CRBP Moran Sean F. 18,800 3.3600 627 100.8000 63,168
2014-12-17 CRBP Moran Sean F. 1,000 3.3000 33 99.0000 3,300
2014-12-17 CRBP Moran Sean F. 600 3.5000 20 105.0000 2,100
2014-12-17 CRBP Moran Sean F. 1,250 3.5800 42 107.4000 4,475
2014-12-11 CRBP Moran Sean F. 1,000 3.9800 33 119.4000 3,980
2014-12-09 CRBP Moran Sean F. 1,200 3.9700 40 119.1000 4,764
2014-12-09 CRBP Moran Sean F. 500 4.0000 17 120.0000 2,000
2014-12-04 CRBP Moran Sean F. 1,000 3.1500 33 94.5000 3,150
2014-12-04 CRBP Moran Sean F. 1,000 3.2500 33 97.5000 3,250
2014-12-02 CRBP Moran Sean F. 1,000 3.0300 33 90.9000 3,030
2014-11-26 CRBP Moran Sean F. 1,000 3.0500 33 91.5000 3,050
2014-11-25 CRBP Moran Sean F. 1,000 3.0000 33 90.0000 3,000
2014-11-25 CRBP Moran Sean F. 1,000 3.0500 33 91.5000 3,050
2014-11-25 CRBP Moran Sean F. 1,000 3.1000 33 93.0000 3,100

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CRBP / Corbus Pharmaceuticals Holdings, Inc. Insider Trades
CRBP / Corbus Pharmaceuticals Holdings, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 CRBP / Corbus Pharmaceuticals Holdings, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

CRBP / Corbus Pharmaceuticals Holdings, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Moran Sean F. 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2026-02-18 2026-02-13 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		S - Sale X -4,701 96,694 -4.64 7.78 -36,588 752,569
2026-01-16 2026-01-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		A - Award 28,082 101,395 38.30
2025-10-27 2025-10-24 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		S - Sale X -12,981 73,313 -15.04 17.02 -220,937 1,247,787
2025-10-27 2025-10-24 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		M - Exercise 12,981 86,294 17.71 4.26 55,299 367,612
2025-02-18 2025-02-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		S - Sale X -2,792 73,313 -3.67 8.76 -24,446 641,921
2025-02-04 2025-01-31 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		A - Award 27,500 76,105 56.58
2024-06-18 2024-06-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		S - Sale X -1,958 48,605 -3.87 42.12 -82,479 2,047,447
2024-06-18 2024-06-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		M - Exercise 1,958 50,563 4.03 30.00 58,740 1,516,890
2024-06-18 2024-06-17 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		S - Sale X -6,730 48,605 -12.16 46.77 -314,789 2,273,450
2024-06-18 2024-06-17 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		M - Exercise 6,730 55,335 13.85 14.10 94,893 780,224
2024-06-18 2024-06-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		S - Sale X -7,788 48,605 -13.81 49.87 -388,417 2,424,116
2024-06-18 2024-06-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		M - Exercise 7,788 56,393 16.02 4.26 33,177 240,234
2024-06-18 2024-06-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		S - Sale X -1,567 48,605 -3.12 49.87 -78,152 2,424,116
2024-06-18 2024-06-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		M - Exercise 1,567 50,172 3.22 30.00 47,010 1,505,160
2024-04-11 2024-04-10 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		M - Exercise 1,787 48,605 3.82 30.00 53,610 1,458,150
2024-02-14 2024-02-12 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock, par value $0.0001 per share 		A - Award 40,176 46,818 604.88
2022-08-10 2022-08-10 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 20,000 199,272 11.16 0.26 5,198 51,791
2022-05-16 2022-05-16 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 12,000 179,272 7.17 0.30 3,600 53,782
2022-03-10 2022-03-10 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 15,000 167,272 9.85 0.37 5,550 61,891
2022-02-02 2022-02-01 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option (right to buy) 		A - Award 538,400 538,400
2021-02-04 2021-02-02 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option (right to buy) 		A - Award 307,300 307,300
2021-02-04 2021-02-02 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option (right to buy) 		A - Award 307,300 307,300
2020-12-22 2020-12-21 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option (Right to Buy) 		M - Exercise -87,500 87,500 -50.00 1.40 -122,500 122,500
2020-12-22 2020-12-21 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		S - Sale X -87,500 349,610 -20.02 1.75 -153,125 611,818
2020-12-22 2020-12-21 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		M - Exercise 87,500 437,110 25.03 1.40 122,500 611,954
2020-12-22 2020-12-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option (Right to Buy) 		M - Exercise -53,610 53,610 -50.00 1.00 -53,610 53,610
2020-12-22 2020-12-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		S - Sale X -53,610 349,610 -13.30 1.40 -75,054 489,454
2020-12-22 2020-12-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		M - Exercise 53,610 403,220 15.33 1.00 53,610 403,220
2020-12-18 2020-12-16 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option (Right to Buy) 		M - Exercise -36,923 36,923 -50.00 0.17 -6,118 6,118
2020-12-18 2020-12-16 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		S - Sale X -36,923 349,610 -9.55 1.32 -48,628 460,436
2020-12-18 2020-12-16 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		M - Exercise 36,923 386,533 10.56 0.17 6,118 64,049
2020-03-09 2020-03-06 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option(right to buy) 		A - Award 226,000 226,000
2019-05-14 2019-05-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 100 349,610 0.03 7.12 712 2,489,223
2019-03-14 2019-03-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,500 349,510 0.43 6.67 10,005 2,331,232
2019-01-18 2019-01-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option(right to buy) 		A - Award 195,000 195,000
2018-05-15 2018-05-15 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 4,000 348,010 1.16 5.77 23,080 2,008,018
2018-03-14 2018-03-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 3,100 344,010 0.91 6.60 20,460 2,270,466
2018-01-05 2018-01-04 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option(right to buy) 		A - Award 175,000 175,000
2018-01-05 2018-01-04 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option(right to buy) 		A - Award 175,000 175,000
2017-11-13 2017-11-10 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,500 340,910 0.44 7.04 10,560 2,400,006
2017-08-11 2017-08-11 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 2,500 339,410 0.74 5.91 14,775 2,005,913
2017-05-12 2017-05-11 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 3,300 336,910 0.99 6.14 20,262 2,068,627
2017-03-13 2017-03-13 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 2,000 333,610 0.60 9.60 19,200 3,202,656
2017-03-03 2017-03-01 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option(right to buy) 		A - Award 115,000 115,000
2016-12-02 2016-12-02 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,500 331,610 0.45 7.20 10,800 2,387,592
2016-10-07 2016-10-06 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option(right to buy) 		A - Award 150,000 150,000
2016-09-08 2016-09-08 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 30,800 330,110 10.29 5.12 157,696 1,690,163
2016-08-26 2016-08-26 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 17,900 299,310 6.36 3.92 70,168 1,173,295
2016-08-18 2016-08-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 65,000 281,410 30.04 3.48 226,200 979,307
2016-08-18 2016-08-17 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 83,960 216,410 63.39 3.19 267,832 690,348
2016-05-19 2016-05-19 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 27,250 132,450 25.90 2.37 64,582 313,906
2016-05-18 2016-05-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 30,000 105,250 39.87 2.39 71,700 251,548
2016-01-11 2016-01-07 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Stock Option(right to buy) 		A - Award 175,000 175,000
2015-12-11 2015-12-11 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 75,250 1.35 1.56 1,559 117,315
2015-12-10 2015-12-10 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 74,250 1.37 1.61 1,611 119,617
2015-12-09 2015-12-09 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 73,250 1.38 1.67 1,670 122,328
2015-12-08 2015-12-08 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 72,250 1.40 1.68 1,682 121,524
2015-12-07 2015-12-07 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 71,250 1.42 1.69 1,689 120,341
2015-12-04 2015-12-04 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 70,250 1.44 1.72 1,720 120,830
2015-12-03 2015-12-02 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 69,250 1.47 1.79 1,790 123,951
2015-11-24 2015-11-24 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,500 68,250 2.25 1.78 2,670 121,485
2015-11-20 2015-11-20 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,500 66,750 2.30 1.70 2,548 113,388
2015-11-18 2015-11-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,500 65,250 2.35 1.71 2,565 111,578
2015-11-17 2015-11-17 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,500 63,750 2.41 1.72 2,583 109,778
2015-11-16 2015-11-16 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 2,000 62,250 3.32 1.69 3,372 104,954
2015-09-16 2015-09-16 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 5,000 60,250 9.05 2.12 10,605 127,790
2015-09-15 2015-09-15 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 5,000 55,250 9.95 2.14 10,720 118,456
2015-09-14 2015-09-14 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 5,000 50,250 11.05 1.96 9,820 98,691
2015-09-11 2015-09-11 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 5,000 45,250 12.42 1.85 9,234 83,568
2015-08-21 2015-08-21 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,400 40,250 3.60 2.06 2,879 82,770
2015-08-19 2015-08-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 38,850 2.64 1.92 1,916 74,452
2015-06-09 2015-06-09 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 6,500 37,850 20.73 3.00 19,500 113,550
2014-12-22 2014-12-18 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 18,800 31,350 149.80 3.36 63,168 105,336
2014-12-18 2014-12-17 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,250 12,550 11.06 3.58 4,475 44,929
2014-12-18 2014-12-17 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 600 11,300 5.61 3.50 2,100 39,550
2014-12-18 2014-12-17 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 10,700 10.31 3.30 3,300 35,310
2014-12-12 2014-12-11 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 9,700 11.49 3.98 3,980 38,606
2014-12-09 2014-12-09 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 500 8,700 6.10 4.00 2,000 34,800
2014-12-09 2014-12-09 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,200 8,200 17.14 3.97 4,764 32,554
2014-12-04 2014-12-04 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 7,000 16.67 3.25 3,250 22,750
2014-12-04 2014-12-04 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 6,000 20.00 3.15 3,150 18,900
2014-12-02 2014-12-02 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 5,000 25.00 3.03 3,030 15,150
2014-12-01 2014-11-26 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 4,000 33.33 3.05 3,050 12,200
2014-11-26 2014-11-25 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 3,000 50.00 3.10 3,100 9,300
2014-11-26 2014-11-25 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 2,000 100.00 3.05 3,050 6,100
2014-11-26 2014-11-25 4 CRBP Corbus Pharmaceuticals Holdings, Inc.
Common Stock 		P - Purchase 1,000 1,000 3.00 3,000 3,000
2013-09-04 2013-09-03 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
COMMON STOCK 		P - Purchase 20,000 60,000 50.00 1.02 20,400 61,200
2013-09-03 2013-08-30 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
COMMON STOCK 		S - Sale 12,000 40,000 42.86 1.47 17,640 58,800
2013-09-03 2013-08-29 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
COMMON STOCK 		S - Sale 28,000 28,000 1.23 34,440 34,440
2013-09-03 2013-08-30 4/A NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
COMMON STOCK 		P - Purchase 12,000 40,000 42.86 1.47 17,640 58,800
2013-09-03 2013-08-29 4/A NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
COMMON STOCK 		P - Purchase 28,000 28,000 1.23 34,440 34,440
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）